 |
Recombinant human glutamic acid decarboxylase 65KDa isoform |
|---|---|
| Trade Name | |
| Orphan Indication | Type I diabetes with residual beta cell function |
| USA Market Approval | USA |
| USA Designation Date | 2010-03-22 00:00:00 |
| Sponsor | Diamyd Therapeutics AB;Linnegatan 89B; |
| |
Recombinant human glutamic acid decarboxylase 65KDa isoform |
|---|---|
| Trade Name | |
| Orphan Indication | Type I diabetes with residual beta cell function |
| USA Market Approval | USA |
| USA Designation Date | 2010-03-22 00:00:00 |
| Sponsor | Diamyd Therapeutics AB;Linnegatan 89B; |